Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?

A J A Keen, E Duncan, A McKillop-Smith, N D Evans, A E Gold

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P
Original languageEnglish
Pages (from-to)670-676
Number of pages6
JournalDiabetic Medicine
Volume29
Issue number5
Early online date16 Apr 2012
DOIs
Publication statusPublished - May 2012

Keywords

  • education
  • patient education
  • Type 1 diabetes

Fingerprint Dive into the research topics of 'Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?'. Together they form a unique fingerprint.

  • Cite this